Adult Congenital Heart Disease Research


Investigator-Initiated Research 

Theodore Abraham, MD UCSF HCM Registry Internal Funding
Anu Agarwal, MD Clinical characteristics and outcomes of patients with congenital heart disease at a tertiary care center Internal Funding
Michelle Albert, MD A National Multicenter Retrospective Review of Stress-Induced Cardiomyopathy (Takotsubo Syndrome) Cases in the United States Internal Funding
Ian Harris, MD Role of Cardiovascular Magnetic Resonance in Pregnant Patients with Cardiovascular Disease Internal Funding
Nisha Parikh, MD  Reproductive Factors, Cardiovascular Disease Risk Factors and Coronary Heart Disease Risk Stratification in Women American Heart Assn. (National Office)
Nisha Parikh, MD Pregnancy Related Factors, Cardiovascular Disease Risk Factors and Cardiovascular Disease Risk Stratification NIH Natl Heart, Lung & Blood Institute
Nisha Parikh, MD Copy of gestational diabetes phenotypes and cardiovascular risk factors NIH Miscellaneous Other
Zian Tseng, MD Long-Term Arrhythmia Outcomes, Heart Failure and Mortality in Adults with Moderate or Complex Congenital Heart Disease Internal Funding

Clinical Trials  

Theodore Abraham, MD A Long-Term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICK-HCM (MYK-461-006) or EXPLORER-HCM (MYK-461-005) Trials (MAVA-LTE). Myokardia
Theodore Abraham, MD A multi-center, randomized, double-blind, placebo-controlled, dose-finding study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of CK-3773274 in adults with symptomatic hypertrophic cardiomyopathy and left ventricular outflow tract obstruction. Cytokinetics